Savara (SVRA) Change in Accured Expenses (2010 - 2026)

Savara's (SVRA) quarterly Change in Accured Expenses came in at -$4.6 million in Q1 2026, down 47.24% year-on-year from -$8.8 million in Q1 2025, and down 227.09% on a QoQ basis from $3.6 million in Q4 2025.

Savara (SVRA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Change in Accured Expenses data on file, last reported at -$4.6 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 47.24% year-over-year to -$4.6 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 82.06% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 14.4% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$4.6 million, down from $3.6 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for SVRA reached as high as $3.6 million in Q4 2025 and fell as low as -$4.6 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged $505529.4 across 5 years, with a median of $1.2 million in 2025.
  • Across the five-year window, Change in Accured Expenses jumped 6075.0% in 2023 and slumped 308.83% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $445000.0 in 2022, then surged by 230.34% to $1.5 million in 2023, then soared by 53.74% to $2.3 million in 2024, then soared by 61.37% to $3.6 million in 2025, then plunged by 227.09% to -$4.6 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$4.6 million in Q1 2026, $3.6 million in Q4 2025, and $3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn - 1.13 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - 931,000.00
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn -176.03 Mn
10 Savara 1.40 Bn 1.40 Bn - -4.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.64 Mn
Mar 31, 2026 -4.64 Mn
Dec 31, 2025 3.65 Mn
Dec 31, 2025 3.65 Mn
Sep 30, 2025 3.12 Mn
Sep 30, 2025 3.12 Mn
Jun 30, 2025 1.19 Mn
Jun 30, 2025 1.19 Mn
Mar 31, 2025 -3.15 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 2.26 Mn
Dec 31, 2024 2.26 Mn
Sep 30, 2024 1.38 Mn
Sep 30, 2024 1.38 Mn
Jun 30, 2024 1.34 Mn
Jun 30, 2024 1.34 Mn
Mar 31, 2024 -770,000.00
Mar 31, 2024 -770,000.00
Dec 31, 2023 1.47 Mn
Dec 31, 2023 1.47 Mn